Randomized trial · people

Mazdutide: 16.65% average weight loss at 60 weeks in GLORY-2

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In a placebo-controlled trial in Chinese adults with obesity, the 9 mg mazdutide arm lost an average of 16.65% of body weight over 60 weeks, and stomach side effects such as vomiting and nausea were common but mostly mild to moderate.

Kind
Randomized trial
Studied in
People
Number studied
461
Published
2026
Journal
JAMA

What they tested

The team tested whether a 9 mg weekly dose of mazdutide, given with diet and exercise, lowers body weight more than placebo in Chinese adults with obesity, and how safe it is.

How the study was done

A double-blind, placebo-controlled, phase 3 randomized trial at 27 hospitals in China, in adults with a BMI (body mass index) of 30 or more, with or without type 2 diabetes. Participants got a weekly under-the-skin shot of 9 mg mazdutide or placebo (a dummy shot) for 60 weeks, alongside a lower-calorie diet and more physical activity, and 461 people who got at least 1 dose were analyzed.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking mazdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

At week 60, body weight fell by an average of 16.65% in the mazdutide group and 1.50% in the placebo group, a between-group difference of 15.15%. A weight drop of 5% or more was reached by 84.3% of the mazdutide group versus 33.1% on placebo. Vomiting (53.1% vs 1.3%), nausea (46.9% vs 3.2%) and diarrhea (39.4% vs 6.5%) were the most common side effects, mostly mild to moderate. Side effects led 2.9% of the mazdutide group to stop treatment, versus 0% on placebo.

What it doesn’t show

The trial included only Chinese adults, with an average age of 33.9 years, and tested a single dose against placebo, not against other weight-loss drugs. It ran for 60 weeks, so it does not show what happens after that.

The paper

Gao et al. Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity: The GLORY-2 Randomized Clinical Trial. JAMA. 2026.

The compound

More studies on Mazdutide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking mazdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo